Robert Daly, MD, MBA, of Memorial Sloan Kettering Cancer Center, describes how new at-home treatment methods changed his delivery of care to patients with lung cancer.
Robert Daly, MD, MBA, of Memorial Sloan Kettering Cancer Center, discussed at-home lung cancer treatments and predicted how it and its benefits will continue to evolve.
Daly co-chaired The American Journal of Managed Care®’s Institute for Value-Based Medicine® held on November 2 in New York City, where presenters discussed at-home and remote cancer treatments. He is a thoracic oncologist who specializes in lung cancer, as well as a health services researcher interested in innovative cancer care systems.
Transcript
Could you explain how at-home or remote treatment methods have affected your delivery of care to patients?
A prime example of these new treatment methods is a pilot study we have ongoing right now at my institution where we're looking at the adoption of extended dosing of immunotherapy for patients with lung cancer. How we deliver that safely is by scheduling a televisit in between their infusional doses in order to do a toxicity check and ensure that they're tolerating the treatments safely.
These visits would otherwise have required those patients to come into the clinic in order to have that done. Now, we're able to do labs at the home and a televisit and provide that same service to ensure that they're getting their care safely.
So, what does that mean for patients? It means rather than having to come in every 3 weeks, they can now come in every 6 weeks. For patients who are working, for patients who have travel plans, for patients who have dependents that they're taking care of, this has had a huge impact on their quality of life.
In the future, what innovations or changes in lung cancer treatment do you anticipate to have the most significant impact on patient outcomes?
Well, one area where I'm really excited, and that ties together well with the virtual care, is subcutaneous immunotherapies. Now, there's the opportunity to potentially provide these lifesaving treatments for patients in the home because the delivery of those treatments now does not require an IV infusion.
So, that's a really exciting area where we could pair televisits, home labs, and subcutaneous injections to potentially untether patients from the cancer center and provide increased access to these treatments for patients not only nationally, but globally, as well.
Congress Urged to Repeal Comstock Act Threatening Reproductive Rights and Public Health
May 16th 2024In a joint letter addressed to Congress, Healthcare Across Borders, Take Back the Court Action Fund, and UltraViolet Action called out the resurgence of the Comstock Act, urging immediate action to repeal this century-old law that threatens reproductive rights and public health in the US.
Read More
Frameworks for Advancing Health Equity: Urban Health Outreach
May 9th 2024In the series debut episode of "Frameworks for Advancing Health Equity," Mary Sligh, CRNP, and Chelsea Chappars, of Allegheny Health Network, explain how the Urban Health Outreach program aims to improve health equity for individuals experiencing homelessness.
Listen
After the ACA Expanded Health Care Access, 2024 Elections May See Voters Demand Affordability
May 15th 2024At the spring conference of the New Jersey Health Care Quality Institute, speakers discussed how health policy, affordability, and transparency may play a role in voters’ decisions.
Read More
Panel Addresses Minority Physician Shortage, Maternal Health at Senate Committee Hearing
May 15th 2024The senate hearing held by the US Senate Committee on Health, Education, Labor, and Pensions, led by Sen. Bernie Sanders (I, Vermont), chairman of the committee, and ranking member Sen. Bill Cassidy, MD, (R, Louisiana), addressed the critical issue of physician and health care worker shortages, as well as the maternal health crisis, in the US.
Read More